1832 Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-619,300
Closed -$133M 743
2020
Q3
$133M Buy
619,300
+132,000
+27% +$28M 0.35% 84
2020
Q2
$90M Buy
487,300
+470,600
+2,818% +$82.5M 0.27% 97
2020
Q1
$2.75M Buy
+16,700
New +$1.94M 0.01% 360
2019
Q1
Sell
-55,500
Closed -$2.75M 706
2018
Q4
$2.75M Buy
+55,500
New +$3.4M 0.01% 317

Other funds holding TDOC

1832 Asset Management's TDOC Position: Q4 2020 in Review

1832 Asset Management sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 619,300 shares — an estimated $133M sold.

1832 Asset Management first reported a position in TDOC in Q4 2018 and held it in 4 quarters. The position peaked at $133M in Q3 2020. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • 1832 Asset Management reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • 1832 Asset Management sold 619,300 Teladoc Health shares in Q4 2020, an estimated $133M.
  • 1832 Asset Management first reported a position in Teladoc Health in Q4 2018 and held it in 4 quarters.
  • 1832 Asset Management's Teladoc Health position peaked at $133M in Q3 2020.
  • 901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on 1832 Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.